The Daily Ticker interviews Austan Goolsbee.
![]()
The Daily Ticker interviews Austan Goolsbee.
![]()
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let’s look at two noteworthy recent insider buys.
![]()
In trading on Wednesday, advertising shares were relative leaders, up on the day by about 1.7%. Leading the group were shares of Lamar Advertising (LAMR), up about 10.9% and shares of Clear Channel Outdoor Holdings (CCO) up about 2.8% on the day.
![]()
Orbitz Worldwide (OWW) reported that second quarter profit fell, and also cut its forecast forL the full year. Net income was $4.6 million, or 4 cents per share, versus $8.9 million, or 8 cents per share in the same period last year.
![]()
Watch out Siri, there’s a new virtual assistant in town. From Nuance Communications (NASDAQ:NUAN) comes Nina, a speech based assistant that uses voice recognition and text-to speech software to help the everyday mobile user.The new app will be far superior than its competitors, such as Apple’s (NASDAQ:AAPL) Siri, according to Nuance. The company says it is the first virtual assistant app to incorporate both speech recognition and voice biometrics. So Nina can not only understand what is being said, but can also identify who is saying it. Nuance also claims Nina has a high level of interactive dialogue and language understanding and allows for personalization, including her visual appearance. The app open software development kit, the first virtual assistant to offer such a program, is available today in the US, United Kingdom and Australia with more languages to come later this year.
![]()
CVS Caremark (NYSE:CVS) reporting their second quarter earnings this morning, posting an EPS of 81 cents, higher than the 80 cents analysts were expecting. Revenue also rose 16.3% to $30.71 billion, but just came below analyst estimates of $30.98 billion. The company said the rise in earnings was due to a contract dispute between Walgreens and Express Scripts. CVS’s main competitor stopped filling prescriptions for Express Scripts patients at the beginning of 2012, allowing CVS to gain some more customers. However, the dispute has been settled and Walgreens will start filling prescriptions again on September 15. CVS also raised its full year forecast on EPS, saying it expects $3.32 to $3.38 a share for the fiscal year. Analysts are expecting earnings to be $3.33.
![]()
Esprit, the Europe-focused clothing retailer, appointed a new CEO and consequently drove its shares to their largest one-day gain in 14 years.Esprit, which has been struggling recently, saw the unexpected resignations of both its CEO and its Chairman back in June. But now, the company has appointed Jose Manuel Martinez Gutierrez as CEO. Gutierrez is currently an executive at Esprit’s larger rival, Inditex, which is the world’s largest fashion retailer. On the news, Esprit shares jumped 28 percent.Now, according to Reuters, Esprit can move ahead with a crucial $2.3 billion restructuring plan, in which the company plans to expand in China and diversify its earnings sources. For more on the latest financial new and analysis, follow us on Twitter @FNNOnline, or check out our website at fnno.com
![]()
LSI Logic (LSI) was upgraded by Goldman Sachs to buy from neutral with a $9 price target as margin expansion should be driven by the firms networking and solid state business. Shares are higher by over four percent.
![]()
Yahoo! Washington Bureau Chief David Chalian interviews Steve Forbes
![]()
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let’s look at two noteworthy recent insider buys.
![]()